Utah: common questions

There is no blanket permission for psychedelic therapy. Health-system psilocybin and MDMA treatment programs. Exceptions, personal-use protections or reduced enforcement do not by themselves authorize treatment services.

Utah SB 266 (2024), Medical Amendments, Utah SB 266 (2024) lets qualifying health systems offer psilocybin and MDMA treatment to patients under a pilot program. Possession outside those programs remains a crime.

Access only through participating health-system programs Possession outside a program remains illegal

We don't have a licensing authority on record for listed providers here.

4 listed; 0 with a license confirmed against an official registry.

Ketamine clinic, Ketamine therapy, IV ketamine infusion therapy.

No stage-specific remote arrangement is documented in these listings. 0 unique listings have a remote-service or support record. Unknown arrangements are not evidence that remote support is unavailable. Preparation and integration are separate from administration; these records do not establish legal permission or clinical eligibility for remote treatment.

No. Laws change often, confirm with the official sources below or a licensed attorney.